New Zealand markets open in 3 hours 11 minutes

Pfizer Inc. (PFE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
29.18-0.10 (-0.34%)
As of 12:49PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 165.33B
Enterprise value 184.74B
Trailing P/E 16.00
Forward P/E 9.15
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.44
Price/book (mrq)1.71
Enterprise value/revenue 2.70
Enterprise value/EBITDA 10.05

Trading information

Stock price history

Beta (5Y monthly) 0.56
52-week change 3-41.10%
S&P500 52-week change 315.95%
52-week high 354.93
52-week low 328.30
50-day moving average 331.22
200-day moving average 336.30

Share statistics

Avg vol (3-month) 330.96M
Avg vol (10-day) 336.07M
Shares outstanding 55.65B
Implied shares outstanding 65.65B
Float 85.64B
% held by insiders 10.04%
% held by institutions 170.77%
Shares short (14 Nov 2023) 457.5M
Short ratio (14 Nov 2023) 41.74
Short % of float (14 Nov 2023) 41.02%
Short % of shares outstanding (14 Nov 2023) 41.02%
Shares short (prior month 12 Oct 2023) 454.57M

Dividends & splits

Forward annual dividend rate 41.64
Forward annual dividend yield 45.60%
Trailing annual dividend rate 31.63
Trailing annual dividend yield 35.57%
5-year average dividend yield 43.78
Payout ratio 489.07%
Dividend date 303 Dec 2023
Ex-dividend date 408 Nov 2023
Last split factor 21054:1000
Last split date 316 Nov 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Sept 2023


Profit margin 15.29%
Operating margin (ttm)-62.32%

Management effectiveness

Return on assets (ttm)2.39%
Return on equity (ttm)11.06%

Income statement

Revenue (ttm)68.54B
Revenue per share (ttm)12.16
Quarterly revenue growth (yoy)-41.60%
Gross profit (ttm)66.23B
Net income avi to common (ttm)10.47B
Diluted EPS (ttm)1.83
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)44.18B
Total cash per share (mrq)7.82
Total debt (mrq)64.13B
Total debt/equity (mrq)65.98%
Current ratio (mrq)2.38
Book value per share (mrq)17.17

Cash flow statement

Operating cash flow (ttm)12.04B
Levered free cash flow (ttm)-470.25M